FDA Drug recall D-0416-2018
Klonopin (clonazepam) 0.5 mg Tablets,100-count bottle, Rx only
- FDA Drug
- Class III
- terminated
- Published 2018-02-21
On 2018-02-21 the FDA classified a Class III recall of Klonopin (clonazepam) 0.5 mg Tablets,100-count bottle, Rx only by Genentech, citing labeling: Not Elsewhere Classified: Schedule IV controlled substance indicator of CIV being omitted from the product carton, primary label is correct.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0416-2018 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2018-02-05 |
| Published | 2018-02-21 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Genentech |
| Distribution | US |
Product
Klonopin (clonazepam) 0.5 mg Tablets,100-count bottle, Rx only. Made in Canada, Distributed by Genentech USA, Inc. A Member of the Roach Group, 1 DNA Way South San Francisco, CA 94080-4990. NDC 0004-0068-01
Reason
Labeling: Not Elsewhere Classified: Schedule IV controlled substance indicator of CIV being omitted from the product carton, primary label is correct.
Identifiers
| code_info | Lot # 3141989, EXP 08/31/2019 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0416-2018%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.